Sequoyitol ameliorates diabetic nephropathy in diabetic rats induced with a high-fat diet and a low dose of streptozotocin

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 5, 2014, Pages 405-417

  Li, Xian Wei ^a   Liu, Yan ^a   Hao, Wei ^a   Yang, Jie Ren ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

Diabetic nephropathy; Oxidative stress; Sequoyitol

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; CREATININE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MALONALDEHYDE; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; SEQUOYITOL; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 5-O-METHYL-MYO-INOSITOL; INOSITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; KIDNEY FUNCTION; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIET, HIGH-FAT; HYPOGLYCEMIC AGENTS; INOSITOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STREPTOZOCIN;

EID: 84899735881     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0307     Document Type: Article

References (35)

1. Bartosz, G. 2003. Total antioxidant capacity. Adv. Clin. Chem. 37: 219-292. doi: 10.1016/S0065-2423(03)37010-6. PMID:12619709.
2. Border, W.A. 1994. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr. Opin. Nephrol. Hypertens. 3(1): 54-58. doi:10.1097/ 00041552-199401000-00007. PMID:7850412.
3. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865): 813-820. doi:10.1038/414813a. PMID:11742414.
4. Chen, X.P., Yang, J.R., Li, X.W., Hao, W., Liu, Y., and Zhang, J.X. 2013. Effects of sequoyitol on expression of NADPH oxidase subunits p22 phox and p47 phox in rats with type 2 diabetic liver disease. Yao Xue Xue Bao, 48(4): 489-494. [In Chinese]. PMID:23833934.
5. Chen, Z.H., Li, J., Liu, J., Zhao, Y., Zhang, P., Zhang, M.X., et al. 2008. Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice. Am. J. Chin. Med. 36(5): 939-951. doi:10.1142/ S0192415X08006363. PMID:19051359.
6. Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., et al. 2002. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 359: 2072-2077. doi:10.1016/S0140-6736(02)08905-5. PMID:12086760.
7. Craven, P.A., DeRubertis, F.R., Kagan, V.E., Melhem, M., and Studer, R.K. 1997. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8(9): 1405- 1414. PMID:9294832.
8. Droge, W. 2002. Free radicals in the physiological control of cell function. Physiol. Rev. 82(1): 47-95. PMID:11773609.
9. Feng, B., Yan, X.F., Xue, J.L., Xu, L., and Wang, H. 2013. The protective effects of _-lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress. Int. J. Mol. Sci. 14(4): 6746-6756. doi:10.3390/ijms14046746. PMID:23531536.
10. Forbes, J.M., Coughlan, M.T., and Cooper, M.E. 2008. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes, 57(6): 1446-1454. doi:10.2337/ db08-0057. PMID:18511445.
11. Geiszt, M., and Leto, T.L. 2004. The Nox family of NAD(P)H oxidases: host defense and beyond. J. Biol. Chem. 279(50): 51715-51718. doi:10.1074/jbc.R400024200. PMID:15364933.
12. Ha, H., and Lee, H.B. 2000. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int. 58(Suppl. 77): S19-S25. doi:10.1046/j.1523-1755.2000.07704.x. PMID:10997686.
13. Huyen, V.T., Phan, D.V., Thang, P., Hoa, N.K., and Ostenson, C.G. 2010. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm. Metab. Res. 42(5): 353-357. doi:10.1055/s-0030-1248298. PMID:20213586.
14. Iglesias-de La Cruz, M.C., Ruiz-Torres, P., Alcami, J., Diez-Marques, L., Ortega-Velazquez, R., Chen, S., et al. 2001. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney. Int. 59(1): 87-95. doi:10.1046/j.1523-1755.2001.00469.x. PMID:11135061.
15. Janero, D.R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipidperoxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9(6): 515-40. doi:10.1016/0891-5849(90)90131-2. PMID:2079232.
16. Kitada, M., Koya, D., Sugimoto, T., Isono, M., Araki, S., Kashiwagi, A., et al. 2003. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes, 52(10): 2603-2614. doi:10.2337/diabetes.52.10.2603. PMID:14514646.
17. Lee, H.B., Yu, M.R., Yang, Y., Jiang, Z., and Ha, H. 2003. Reactive oxygen speciesregulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14(8 Suppl. 3): S241-S245. doi:10.1097/01.ASN.0000077410.66390.0F. PMID: 12874439.
18. Lee, K.Y., Ito, K., Hayashi, R., Mreich, E., Twigg, S., Gilbert, R.E., et al. 2006. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J. Immunol. 176(1): 603-615. PMID:16365456.
19. Lee, S.H., Nam, B.Y., Kang, E.W., Han, S.H., Li, J.J., Kim, do., et al. 2010. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrol. Dial. Transplant. 25(7): 2134-2141. doi:10.1093/ndt/gfq063. PMID:20157172.
20. Li, S.H., Zhang, H.J., Niu, X.M., Yao, P., Sun, H.D., and Fong, H.H. 2003. Chemical constituents from Amentotaxus yunnanensis and Torreya yunnanensis. J. Nat. Prod. 66(7):1002-1005. doi:10.1021/np030117b. PMID:12880325.
21. Melhem, M.F., Craven, P.A., and Derubertis, F.R. 2001. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J. Am. Soc. Nephrol. 12(1):124-133. PMID:11134258.
22. Qi, W., Chen, X., Holian, J., Mreich, E., Twigg, S., Gilbert, R.E., et al. 2006. Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am. J. Physiol. Renal. Physiol. 291(5): F1070-F1077. doi:10.1152/ajprenal.00013.2006. PMID:16720864.
23. Rosen, P., and Osmers, A. 2006. Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose. Horm. Metab. Res. 38(9): 575-586. doi:10.1055/s-2006-950397. PMID:16981139.
24. Russo, L.M., del Re, E., Brown, D., and Lin, H.Y. 2007. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes, 56(2): 380-388. doi:10.2337/db06-1018. PMID:17259382.
25. Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., et al. 2005. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol. 288(6): F1144-F1152. doi:10.1152/ ajprenal.00221.2004. PMID:15687247.
26. Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., et al. 2010. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 299(6): F1348-F1358. doi:10.1152/ajprenal.00028. 2010. PMID:20630933.
27. Sheares, K.K., Jeffery, T.K., Long, L., Yang, X., and Morrell, N.W. 2004. Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287(5): L919-L927. doi:10.1152/ajplung.00012.2004. PMID:15220111.
28. Shen, H., Shao, M., Cho, K.W., Wang, S., Chen, Z., Sheng, L., et al. 2012. Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and _-cells. Am. J. Physiol. Endocrinol. Metab. 302(8): E932-E940. doi:10.1152/ajpendo.00479.2011. PMID:22297305.
29. Sivakumar, S., Palsamy, P., and Subramanian, S.P. 2010. Attenuation of oxidative stress and alteration of hepatic tissue ultrastructure by D-pinitol in streptozotocin-induced diabetic rats. Free Radic. Res. 44(6): 668-678. doi:10. 3109/10715761003733901. PMID:20370563.
30. Sun, Y.M., Su, Y., Li, J., and Wang, L.F. 2013. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem. Biophys. Res. Commun. 433(4): 359-361. doi:10.1016/j.bbrc.2013.02. 120. PMID:23541575.
31. Thannickal, V.J., and Fanburg, B.L. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. 279(6): L1005-L1028. PMID:11076791.
32. Wang, A., Ziyadeh, F.N., Lee, E.Y., Pyagay, P.E., Sung, S.H., Sheardown, S.A., et al. 2007. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am. J. Physiol. Renal Physiol. 293(5): F1657-F1665. doi:10.1152/ajprenal.00274.2007. PMID: 17804483.
33. Yang, X.W., Zou, L., Wu, Q., and Fu, D.X. 2008. Studies on chemical constituents from whole plants of Crossostephium chinense. Zhongguo Zhong Yao Za Zhi, 33(8): 905-908. PMID:18619349.
34. Yuan, L., Wang, Y., Lu, C., and Li, X. 2013. Angiotensin-converting enzyme 2 deficiency aggravates glucose intolerance via impairment of islet microvascular density in mice with high-fat diet. J. Diabetes. Res. 2013: 405284. doi: 10.1155/2013/405284. PMID:23671869.
35. Zhang, M., Lv, X.Y., Li, J., Xu, Z.G., and Chen, L. 2008. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp. Diabetes. Res. 2008: 704045. doi:10.1155/2008/704045. PMID: 19132099.